When analyzing patients with oropharyngeal carcinomas according to HPV status, we observed that in HPV-negative tumors, the advantage in local recurrence-free survival was maintained for patients in Group 1 (5-year local recurrence-free survival for patients in Group 1 66.9% versus 12.9% for patients in Group 2), although the differences did not reach statistical significance ( p = 0.123).
← all excerpts
Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy.
1
0.1230
0.1230